Dr. William Joseph Barrish, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 329 Mullet Run, Milford, DE 19963 Phone: 302-424-4141 Fax: 302-422-6506 |
Dr. Maryum Rafique, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1197 Airport Rd Fl 2, Milford, DE 19963 Phone: 844-365-7246 Fax: 844-516-0080 |
Sameena Malhan, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 21 W Clarke Ave, C/o Rehab Dept, Milford, DE 19963 Phone: 302-381-8880 |
Jay Ira Freid, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 111 Neurology Way, Milford, DE 19963 Phone: 302-422-0800 |
Peter Joseph Coveleski, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 111 Neurology Way, Milford, DE 19963 Phone: 302-422-0800 Fax: 888-990-1108 |
News Archive
Casual, no-strings sexual encounters are increasingly common on college campuses, but are some students more likely than others to "hook up"? A new study by researchers with The Miriam Hospital's Centers for Behavioral and Preventive Medicine, published online by the Archives of Sexual Behavior, suggests there are certain factors and behaviors associated with sexual hookups, particularly among first-year college women.
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2010, and company highlights.
A Minneapolis Star Tribune business columnist details a crucial choice one engineering firm made for its future Defense or health care. Health care, was Mid-Continent Engineering's answer. The firm has evolved from building parts for ship board Navy computers to high precision pivoting MRI machine arms as part of its strategy to swing from losses to profits, fend off the recession and ensure a lucrative future.
Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced an agreement with Raptor Pharmaceuticals Inc. to provide genetic testing services for Raptor's clinical trial (RP103-MITO-001) evaluating RP103 as a potential treatment for Leigh syndrome and other inherited mitochondrial disorders.
› Verified 6 days ago